Engineered lactobacilli display anti-biofilm and growth suppressing activities against Pseudomonas aeruginosa

BioRxiv : the Preprint Server for Biology
T. C. Chappell, Nikhil Unni Nair


Biofilms are an emerging target for new therapeutics in the effort to address the continued increase in resistance and tolerance to traditional antimicrobials. In particular, the distinct nature of the biofilm growth state often means that traditional antimicrobials, developed to combat planktonic cells, are ineffective. Biofilm treatments are designed to both reduce pathogen load at an infection site and decrease the development of resistance by rendering the embedded organisms more susceptible to treatment at lower antimicrobial concentrations. In this work, we developed a new antimicrobial treatment modality by characterizing the natural capacity of two lactobacilli, L. plantarum and L. rhamnosus, to inhibit P. aeruginosa growth, biofilm formation, and biofilm viability. We further engineered these lactic acid bacteria (LAB) to secrete enzymes known to degrade P. aeruginosa biofilms and show that our best performing engineered LAB, secreting a pathogen-derived enzyme (PelAhyd), degrades up to 85 % of P. aeruginosa biofilm.

Related Concepts

Reposition-joint Movement
Pharmacologic Substance
Ligands Activity
Validation Methods
Computed (Procedure)

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

International Journal of Molecular Sciences
Qing Wei, Luyan Z Ma
Journal of Microbiology and Biotechnology
Keehoon Lee, Sang Sun Yoon
ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
R M Donlan
Journal of Proteome Research
Sébastien VilainThierry Jouenne
© 2020 Meta ULC. All rights reserved